New Pill May Kill the Flu Virus in Patients in 24 Hours
Japanese drug maker Shionogi has created an experimental compound delivered via a single-dose pill that has been shown to effectively kill the influenza (flu) virus in patients within a single day.
Study Finds 2017-18 Flu Vaccine More Protective Than Believed, Especially Among Children
With many reports about this year’s influenza (flu) vaccine ineffectiveness, a new study shows it is more effective than thought, especially among children.
Universal Flu Vaccine Begins Two-Year Clinical Trial
Researchers at the University of Oxford have begun a two-year clinical trial to test a universal influenza (flu) vaccine in more than 2,000 patients.
Clinical Trial of Universal Flu Vaccine Is a Success
Scientists at the National Institutes of Health, Frederick National Laboratory for Cancer Research and the University of Melbourne in Australia tested a new universal flu vaccine that produced good immunity against several different strains of influenza viruses.
Study Shows Impact of Age and Pre-Existing Influenza Immune Responses in Older and Younger Adults
In an effort to understand how current influenza vaccines are influenced by preexisting immunity in people of different ages, researchers vaccinated volunteers ages 18 years to 85 years with split, inactivated Fluzone influenza vaccine in four consecutive seasons from 2013 to 2016, and assessed the impact of repeated vaccination on breadth and durability of antibodies as a result of vaccine strain changes.
Study Shows a Positive Mood Could Boost Effectiveness of Flu Vaccine
Researchers at the University of Nottingham in England have found evidence that being in a positive mood when receiving an influenza (flu) vaccine can increase its protective effect.
Flublok: A Potent New Weapon Against the Shape-Shifting Influenza Virus
The best defense against influenza remains annual immunization against emergent influenza strains.
CDC Study Shows Flu Vaccine Reduces Risk of Death in Children
A new study conducted by the Centers for Disease Control and Prevention shows that during the years 2010 through 2014, the influenza vaccine reduced the risk of flu-associated death by half among children with underlying high-risk medical conditions and by nearly two-thirds among healthy children.
The Rising Costs of Influenza Pandemics
It’s not a matter of if, but rather when, the next flu pandemic will occur, so preparations are being made now to save lives and reduce costs.
Flu Vaccine May Cause Immune-Related Adverse Events with Checkpoint Inhibitors
Study results from the division of oncology at University Hospital Basel in Switzerland show that patients treated with PD-1/PD-L1 checkpoint inhibitors may be at an increased risk for adverse events after receiving the seasonal influenza vaccination.
